A sample report on
Belgium Patient
Support Programs
(PSP) Market
Analysis
Includes Market Size, Market Segmented by
Types and Key Competitors (Data forecasts
from 2023 – 2030F)
www.insights10.com
This report presents a strategic analysis of the Belgium Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Belgium Patient Support Programs (PSP) Market, and offers unmatched value, accuracy, and expert insights.
Report Scope
Report Attribute
Details
Number of Pages
70-80
Base Year for Estimation
2022
Forecast Period
2023-2030
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Report Coverage
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario
Quantitative Units
Revenue in USD Million/Billion (Mn/Bn)
Research Approach
Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 3
Table of Content
CONTENT
PG. NO.
1. Patient Support Programs (PSP) Overview
06-19
1.1. Overview
1.2. Belgium Overview
1.3. Economic Overview: Belgium
1.4. Patient Support Programs (PSP) Market in Belgium 1.5. Healthcare Services Market in Belgium
1.6. Healthcare Scenario in Belgium
1.7. Health Insurance Coverage: Belgium
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting
20-26
2.1 Market size and forecasts (Excel and Methodology) A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 4
Table of Content
CONTENT
PG. NO.
2.2. Market Segmentation
3. Market Dynamics
27-31
3.1. Market Growth Drivers
3.2. Market Restraints
4. Competitive Landscape
32-42
4.1. Major Market Share
4.2. Key Company Profile
5. Reimbursement Scenario
43-48
5.1. Reimbursement Regulation
5.2. Reimbursement Process for Diagnosis
5.3. Reimbursement Process for Treatment
6. Methodology & Scope
49-54
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 5
Belgium Patient Support Programs (PSP) Market Analysis 1. Patient Support Programs (PSP) Overview
1.1 Statistics at a Glance: Patient Support Programs (PSP) in the World Patient Support Programs (PSP) at
Global level
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
90%
32%
report
Was PSPs impact
Is the percentage increase in
adherence after one
number of PSP in the US
▪
In this section you will get an
year
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
$70.3 Bn
17.4%
topic
Is the forecasted
Is the CAGR of the Global
valuation of Global
PSP market for the period of
▪
In order to obtain access to all of the
PSP market for
2023-2030
information that you are seeking, you will
year 2030
need to purchase the final report
▪
Final report will be comprehensive and
Unaffordability and Non-adherence
detailed, and it will include data, analysis,
Are the major reasons for the impact of PSP market
trends, and other relevant information
related to the topic or subject matter of
interest
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 7
1.1 Statistics at a Glance: Patient Support Programs (PSP) in the World (continued)
North America
Belgium Market
Asia
~ Market Size of
XX Mn Market
-xx CAGR
XX Bn
Africa
~Market Size of XX
Bn
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 8
1.2 Belgium Overview
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪
In this section you will get an
understanding of the demographics of the
country/region, which includes the
11.65 Mn
$554.6 Bn
population, GDP, healthcare expenditure
and other details related to the topic
Is the population of
Is the Gross
Belgium, in 2022
Domestic Product
▪
In order to obtain access to all of the
(GDP) in Belgium in
information that you are seeking, you will
2022
need to purchase the final report
▪
Final report will be comprehensive and
42.3 years
$5009.46
detailed, and it will include data, analysis,
Is the median age
Per capita was the
trends, and other relevant information
in Belgium, in 2022
amount of national
related to the topic or subject matter of
health expenditures in
interest
2022
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 9
1.3 Economic Overview: Belgium
Population of Belgium, (2020-2030)
GDP of Belgium, (2020-2030)
XX
XX
XX
XX
2020
2021
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
2020
2021
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population Split (2023)
▪
In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, By Gender
By Age Group
healthcare expenditure and other details related to the topic
▪
In order to obtain access to all of the information that you are 0-14
seeking, you will need to purchase the final report
15-24
Female
Male
▪
Final report will be comprehensive and detailed, and it will 51%
49%
25-54
include data, analysis, trends, and other relevant information 55-64
related to the topic or subject matter of interest
65+
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 10
1.4 Patient Support Programs (PSP) in Belgium
▪
Please be aware that this sample report
Main service providers in Patient support programs is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
▪
Government Agencies
final report
▪
Pharmaceutical Companies
▪
In this section you will get an
▪
Healthcare Providers and
understanding of the topic, which
Institutions
includes the prevalence of the disease,
▪
Patient Advocacy Groups
the application of medical devices, new
▪
Non-profit Organizations
technology, and other details related to
the topic in Belgium
Main services provided in Patient support programs
▪
In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪
Health Education and support
▪
Practical support
▪
Final report will be comprehensive and
detailed, and it will include data,
▪
Medication assistance
▪
Call Center Support
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 11
1.5 Healthcare Services in Belgium
Belgium Healthcare Services Market Forecast, 2022-2030 (in $Bn) 2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report
▪
In this section you will get an understanding of the overall Healthcare Services market in Belgium, which includes the market size, current trends and other details related to the topic
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 12
1.6 Healthcare Scenario in Belgium
Belgium has a highly developed healthcare system that provides universal coverage for its residents. The healthcare system in Belgium is funded through a combination of social security contributions and taxes, ensuring that everyone has access to healthcare services
▪
Universal Coverage: Belgian healthcare system provides universal coverage, which means that all legal residents have access to necessary healthcare services. Non-residents may also receive emergency care
▪
Health Insurance: All residents are required to have health insurance, either through a government-run health insurance scheme or private health insurance. The government insurance scheme is compulsory and covers a significant portion of the healthcare costs, while private insurance can provide additional coverage and benefits
▪
Primary Care: Primary healthcare in Belgium is typically provided by general practitioners (GPs) who act as gatekeepers to specialized care. Patients usually consult their GP first, who may then refer them to specialists or hospitals if needed
▪
Specialist Care and Hospitals: Belgium has a well-developed network of hospitals and specialized healthcare providers. Patients can choose their healthcare providers and have the freedom to visit any hospital or specialist without a referral from a GP, although this may affect reimbursement levels
▪
Reimbursement System: Belgian healthcare system operates on a reimbursement model. Patients pay for healthcare services upfront and then submit reimbursement claims to their health insurance provider. Reimbursement rates depend on the type of service and the insurance coverage
▪
Pharmaceuticals: Belgium has a comprehensive pharmaceutical system, and prescription medications are available through pharmacies.
The cost of prescription drugs is generally partially reimbursed, with patients paying a co-payment Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 13
1.6 Healthcare Scenario: Patient Journey
Presentation
Diagnosis
Treatment
Follow up
Confirmatory Diagnosis
Complete blood count
Prevention and management of
(evaluate number &
crisis:
quality of RBCs, Hb &
• For VOC and Splenic
• Long term follow-up is required for
WBCs)
patients with SCD
Initial Diagnosis
Sequestration: HU, Endari,
Adakveo, Oxbryta
• Annual assessment: CBC and
A suspected diagnosis is
Imaging (confirm bone
• For infections: Antibiotics,
reticulocyte count, iron status, liver
usually made, based on
related changes or
Vaccines
and renal function tests, urinalysis,
physical examination and
respiratory problems)
Prenatal screening/
LDH, vitamin D level and
detailed patient and family
Neonatal screening
Bacterial cultures of
neurocognitive assessment
history
blood, sputum, urine,
• ESOD (End Stage Organ Damage)
stool (detect any
Prevention and management of
evaluation starting from age 7
infection)
complications:
• Yearly Transcranial Doppler test to
determine risk of stroke
Genetic testing (detect
• Stroke: Chronic transfusions, HU
the type of SCD)
sr
PCP, pediatrician, neonatologist,
ed
endocrinologist, cardiologist,
l
PCP, paediatrician,
PCP, pediatrician, medical geneticist,
o
neonatologist,
PCP, pediatrician, medical geneticist,
hematologist, orthopedist, psychologist
cardiologist, hematologist,
haematologist and genetic
hematologist, gynecologist and pathologist
and psychiatrist
endocrinologist, psychologist and
counsellor
psychiatrist
Depending on the organ complications,
Stakeh
the treatment involves different
specialists at different times
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 14
1.7 Health Insurance Coverage: Belgium
% of People by Type of Health Insurance Coverage
Number of People By Health Insurance Coverage
(2021)
Coverage Type
2020
2021
Change %
Uninsured
8.3
Total
327,521
328,074
With health insurance
91.7
Any health plan
299,230
300,887
0.4
Any private plan
217,896
216,366
–0.6
Any private plan
66.0
Employment-based
178,737
178,285
–0.2
Employment-based
54.3
Direct-purchase
10.2
Direct-purchase
33,869
33,555
–0.1
Marketplace
3.5
Marketplace coverage
10,924
11,389
0.1
TRICARE
2.5
TRICARE
9,165
8,299
–0.3
Any public plan
112,925
117,095
1.2
Any public plan
35.7
VA and CHAMPVA
2,967
3,151
0.1
VA and CHAMPVA
1.0
Uninsured
28,291
27,187
–0.4
▪
In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year
▪
Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Private (18.9%), Public (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 15
1.8 Budget of Belgium Government for Public Insurance Proposed Budget By Category
Outlays
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2022-31
$769
$709
$766
$841
$840
$947
$1,014
$1,085
$1,227
$1,178
$1,325
$1,412
$10,633
In Billions Of Dollars
$458
$521
$571
$582
$616
$645
$674
$698
$734
$768
$801
$837
$6,926
Public
3.7%
3.2%
3.3%
3.4%
3.3%
3.6%
3.7%
3.8%
4.1%
3.8%
4.1%
4.2%
3.7%
As % Of GDP
2.2%
2.4%
2.4%
2.4%
2.4%
2.4%
2.4%
2.4%
2.5%
2.5%
2.5%
2.5%
2.4%
▪
National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪
Public spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪
Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪
Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪
Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪
Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪
Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪
Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪
Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 16
1.9 Mergers and Acquisitions
RCM M&A Deal Value Trend ($Bn)
RCM M&A Deal Volume Trend
$16.7
112
107
107
110
89
$11.7
82
$10.5
$7.7
$6.8
$6.0
1H 2020
2H 2020
1H 2021
2H 2021
1H 2022
2H 2022
1H 2020
2H 2020
1H 2021
2H 2021
1H 2022
2H 2022
Buyer Composition: Strategic Vs Financial (2020)
Buyer Type by Deal Size
41%
41%
42%
39%
($Mn)
59%
59%
58%
61%
Strategic Buyers
Financial Buyers
$0- $25
$25-$50
$50-$100
$100+
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020 Illustrative A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 17
1.9 Mergers and Acquisitions (continued)
Latest Deals In Belgium
Amount /
Company Name
Type
Year
Key Pointers
Duration
▪
Acquisition of PatientConnect by ERT will allow ERT to expand its patient support program capabilities in Belgium and across Europe
▪
PatientConnect is a leading patient support services company in October,
Acquisition
$191 Mn
Belgium, with a strong track record of providing high-quality 2022
services to pharmaceutical companies
▪
Acquisition will give ERT access to PatientConnect's expertise ERT acquisition of
and resources, which will help ERT to grow its business in PatientConnect
Belgium and across Europe
▪
Patient Access Solutions is a leading patient support services company in Belgium, with a strong track record of providing high-quality services to pharmaceutical companies
▪
Acquisition will give Syneos Health access to PatientAccess Acquisition
$165 Mn
July 2022
Solutions' expertise and resources, which will help Syneos Health to grow its business in Belgium and across Europe
Syneos Health
▪
Acquisition of Patient Access Solutions by Syneos Health will acquisition of Patient
allow Syneos Health to expand its patient support program Access Solutions
capabilities in Belgium and across Europe
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 18
1.9 Mergers and Acquisitions (continued)
Latest Deals In Belgium
Amount /
Company Name
Type
Year
Key Pointers
Duration
Merger
March 2023
Merger
Jan 2023
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 19
Belgium Patient Support Programs (PSP) Market Analysis 2. Market Size and Forecasting
2.1 Market size and forecasts (Excel and Methodology) Click on the icon to know the
Belgium PSP Market Forecast, 2022-2030 (in $Bn)
methodology and assumption
▪
Please be aware that this sample report
XX
is intended to provide you with a brief
XX
overview of the kind of information and
analysis that will be presented in the
final report
▪
In this section you will get an
understanding of the overall Healthcare
Insurance market in Malaysia, which
includes the market size, current trends
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
and other details related to the topic
2023
2024
2025
2026
2027
2028
2029
2030
▪
In order to obtain access to all of the
Major Markets Patient
2.74
2.82
2.90
2.94
2.98
3.02
3.07
3.12
information that you are seeking, you
(Mn)
will need to purchase the final report
Belgium Patient Size (Bn)
0.51
0.61
0.68
0.69
0.70
0.71
0.72
0.73
▪
Final report will be comprehensive and
detailed, and it will include data,
% of US Patients
18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
analysis, trends, and other relevant
Global Market Size (Bn $)
3,620
3,780
3,950
4,128
4,314
4,508
4,711
4,937
information related to the topic or
subject matter of interest
Belgium Market Size (Bn
61
74
84
87
91
95
99
106
$)
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 21
2.2 Snapshot of PSP Market Segmentation
Functionality
Therapeutic Area
Application
End-user
Population Health
Communication
Health & Wellness
Payers
Management
Health Tracking &
Chronic Disease
Outpatient Health
Providers
Insights
Management
Management
In-patient Health
Billing & Payments
Others
Management
Others
Administrative
Others
Patient Education
▪
In this section you will get an understanding of the segmentations which will cover the Belgium Patient Support Programs (PSP)
Market
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 22
2.2.1 Market Segmentation: By Functionality
▪
Communication market in Belgium is a
significant component of the overall
Belgium PSP Market Share, By Functionality (2022)
PSP treatment market
▪
It has the maximum market share in
Patient
Belgium PSP market with
Education
approximately xx%
▪
Please be aware that this sample report
Administrative
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
Communication
final report
▪
In order to obtain access to all of the
information that you are seeking, you
Billing &
will need to purchase the final report
Payments
▪
Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
Health Tracking
subject matter of interest
& Insights
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 23
2.2.2 Market Segmentation: By Therapeutic Area
▪
Health & wellness market in Belgium is
a significant component of the overall
Belgium PSP Market Share, By Therapeutic Area (2022) PSP market
▪
It has the maximum market share in
Belgium PSP market with
approximately xx%
Others
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
Health &
Wellness
final report
▪
In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
Chronic Disease
information related to the topic or
Management
subject matter of interest
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 24
2.2.2 Market Segmentation: By Application
▪
Population health management market
in Belgium is a significant component of
Belgium PSP Market Share, By Application (2022)
the overall PSP market
▪
It has the maximum market share in
Belgium PSP market with
Others
approximately xx%
▪
Please be aware that this sample report
is intended to provide you with a brief
Population
Health
overview of the kind of information and
Management
analysis that will be presented in the
In-patient Health
final report
Management
▪
In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
Outpatient
subject matter of interest
Health
Management
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 25
2.2.3 Market Segmentation: By End User
▪
Payers have the maximum market
share in Belgium PSP market with
Belgium PSP Market Share, By End User (2022)
approximately xx%
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
Others
analysis that will be presented in the
final report
▪
In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪
Final report will be comprehensive and
Payers
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Providers
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 26
Belgium Patient Support Programs (PSP) Market Analysis 3. Market Dynamics
3.1 Market growth drivers
3.1.1 Increasing prevalence of chronic diseases, prevalence of cardiovascular diseases was 30% and prevalence of cancer was 25% in 2022
▪
Number of people living with chronic diseases in Belgium is Increasing prevalence of chronic
increasing
diseases in Belgium
▪
This is due to a number of factors, including the aging population, the rising prevalence of obesity, and the increasing environmental pollution
▪
As the number of people living with chronic diseases
increases, the demand for patient support programs is also expected to increase
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information 2010
2022
2030
related to the topic or subject matter of interest
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 28
3.1 Market growth drivers (continued)
3.1.2 Increasing awareness for importance of patient engagement, government has initiated many healthcare programs including, MyHealth@Home Program, Patient Empowerment Program and Patient Advocacy Network
▪
There is a growing recognition of the importance of patient Increasing government funding for PSPs
engagement in healthcare
in Belgium
▪
Patient engagement refers to the active participation of patients in their own care
▪
Patient support programs can help to improve patient
engagement by providing patients with the information and support they need to take an active role in their care
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
2010
2022
2030
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 29
3.2 Market restraints
3.2.1 Data security and privacy
3.2.2 High cost of patient
3.2.3 Lack of awareness, only
concerns, 75% of patients are
support programs, the average
30% of patients are aware of
concerned about the security
cost of a PSP in Belgium is
patient support programs in
of their health data
around $1,104 per participant
Belgium
▪
Please be aware that this sample
▪
Please be aware that this sample
▪
Please be aware that this sample
report is intended to provide you
report is intended to provide you
report is intended to provide you
with a brief overview of the kind of
with a brief overview of the kind of
with a brief overview of the kind of
information and analysis that will
information and analysis that will
information and analysis that will
be presented in the final report
be presented in the final report
be presented in the final report
▪
In order to obtain access to all of
▪
In order to obtain access to all of
▪
In order to obtain access to all of
the information that you are
the information that you are
the information that you are
seeking, you will need to
seeking, you will need to
seeking, you will need to
purchase the final report
purchase the final report
purchase the final report
▪
Final report will be
▪
Final report will be
▪
Final report will be
comprehensive and detailed, and
comprehensive and detailed, and
comprehensive and detailed, and
it will include data, analysis,
it will include data, analysis,
it will include data, analysis,
trends, and other relevant
trends, and other relevant
trends, and other relevant
information related to the topic or
information related to the topic or
information related to the topic or
subject matter of interest
subject matter of interest
subject matter of interest
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 30
Belgium Patient Support Programs (PSP) Market Analysis 4. Competitive Landscape
4.1 Major Market Share
▪
Belgium PSP market is a highly
Revenue of Major players in Belgium PSP Market ($ Mn) competitive space, with many companies
developing and marketing PSP treatments
Other
▪
Some of the top companies in Belgium
PSP market based on revenue and market
share include
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪
In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data, analysis,
XX
trends, and other relevant information
related to the topic or subject matter of
interest
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 32
4.2 Key Company Profile
Key Note:
1
IQVIA
▪
Here is the list of top 10 companies which
will cover in the final report
2
Inizio Engage
▪
Each company will have slides for
o Overview
3
Domo Health
o Key details
4
Comarch
o Offerings
o Name of products
5
Simmons & Simmons
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
6
Remedus
o Mergers, Acquisitions and
Collaboration
7
Novellas healthcare
o Financials
8
Ashfield Engage
▪
If there are specific companies that you
would like to be included in the report,
please let us know via email
9
Healthentia
▪
In order to obtain access to all of the
Marti farm
information that you are seeking, you will
10
need to purchase the final report
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 33
4.2.1 IQVIA
Solutions offered by IQVIA
▪
IQVIA is a world leader in using data, technology, advanced Founded in: 1982
analytics and human expertise to help customers drive
➢ Hospital solutions
healthcare - and human health – forward
HQ: Durham, US
▪
➢
IQVIA has over 79,000 employees and operates in more than Business intelligence & data science
100 countries
Type: Public
➢ Sales, medical & marketing services
▪
Company's expertise, experience, and scalability make it a Revenue: $15.150 Bn
valuable partner for pharmaceutical companies, biotechnology
➢ Commercial technologies
companies, medical device companies, and government
Website: www.iqvia
➢ Real world evidence
agencies
➢ Activation services
Numerous patient support programs offered
Financial assistance
Education and Counselling
Technology enabled engagement
Clinical support and intervention
Co-pay management
Home nurse visits
Remote monitoring
Drug administration
Claims support
Inbound support line
Patient apps
Home based clinical support
Prior authorization
Outbound calls/reminders
Artificial intelligence
Medical tests
Loan management
SMS reminders
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 34
4.2.1 IQVIA (continued)
Partnerships Ecosystem
Major Vendor Partners
IQVIA and Athenahealth work together to provide patient support programs that are integrated with EHRs, making it easier for patients to access the information and services they need Cognizant is a global information technology company that provides a wide range of services to the healthcare industry. IQVIA and Cognizant work together to provide patient support programs that are designed to improve patient adherence and outcomes
Evolent Health is a healthcare technology company that provides a platform for healthcare providers to collaborate and share data. IQVIA and Evolent Health work together to provide patient support programs that are data-driven, making it easier for providers to track patient progress and identify areas for improvement
HealthcareSource is a healthcare staffing company that provides a range of services to healthcare providers, including patient support services
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 35
4.2.1 IQVIA (continued)
Latest Deals - Mergers and Acquisitions
Amount /
Company Name
Type
Year
Key Pointers
Duration
▪
Partnership between IQVIA and Janssen will combine IQVIA's patient support program expertise with Janssen's deep understanding of its products
▪
This will allow the two companies to create patient support Partnership
-
January, 2023
programs that are tailored to the specific needs of Janssen's Janssen
patients
▪
Partnership will also leverage IQVIA's technology solutions to provide Janssen with a more data-driven approach to patient support
▪
MedaCare is a leading patient support services company in Belgium
▪
Company provides a range of services to pharmaceutical companies, including patient education, monitoring, and Acquisition
$191 Mn
March 2022
MedaCare
adherence support
▪
IQVIA's acquisition of MedaCare will allow the company to expand its patient support program capabilities in Belgium and across Europe
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 36
4.2.1 IQVIA (continued)
Revenues ($Bn), 2020-2030
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪
In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
2020
2021
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
availability
▪
In order to obtain access to all of the
Breakdown of Net Revenue by Segment, 2022
information that you are seeking, you will
need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
1
2
3
4
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 37
4.2.2 Healthentia
▪
Solutions offered by Company
In 2021, Healthentia medical device entered the market of Founded in:
Patient Support Programs (PSP) as a decision support software intended to monitor, detect and predict outcomes, offer virtual HQ:
coaching services and generate automatic alerts regarding Type:
events, based on Real World Data gathered from patients
▪
Healthentia PSPs are offered jointly with healthcare
Revenue:
organizations and pharmaceutical companies and follow co-development, participatory-design, and patient-centric Website:
approaches
Drugs for PSP
Recent Activity / Press Coverage
Drugs
Indications
• In 2022 Healthentia is expected to collect evidence that will create clinical claims on its efficacy as a therapeutic device.
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 38
4.2.2 Company 2 (continued)
Partnerships Ecosystem
Major Distribution Partners
Major Vendor Partners
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 39
4.2.2 Company 2 (continued)
Latest Deals - Mergers and Acquisitions
Amount /
Company Name
Type
Year
Key Pointers
Duration
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 40
4.2.2 Company 2 (continued)
Revenues ($Bn), 2020-2030
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
xx
xx
report
xx
▪
In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
2020
2021
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
availability
▪
In order to obtain access to all of the
Breakdown of Net Revenue by Segment, 2022
information that you are seeking, you will
need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
1
2
3
4
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 41
Belgium Patient Support Programs (PSP) Market Analysis 5. Reimbursement Scenario
5.1 Reimbursement Regulation
Public and Private together provide
The reimbursement scenario in the Belgium PSP market is complex and can vary health insurance coverage for more than
depending on the specific treatment, setting of care, and insurance coverage.
Here are some key points to consider:
4 in 10 Belgians
▪
Public:
o Public is a federal health insurance program for people aged 65 and older, as well as people with certain disabilities or health conditions o Public covers many PSP treatments, including chemotherapy, radiation therapy, and some immunotherapies
Uninsured
o However, coverage can be subject to strict guidelines and restrictions, 14%
such as the requirement for prior authorization
Public
▪
23%
Private:
o Private is a joint federal-state program that provides health insurance for people with low incomes
o
Employer-Sponsored
Private coverage for PSP treatments can vary by state, and may be 47%
subject to limits on the amount and type of treatment covered
▪
Private Insurance:
o Private insurance coverage for PSP treatments can also vary widely depending on the insurer and the specific policy
o Some policies may have high out-of-pocket costs, such as deductibles Private
and co-pays, while others may have more comprehensive coverage 16%
Health Insurance Coverage, 2022
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 43
5.1 Reimbursement Regulation (continued)
▪
Affordable Care Act:
o Affordable Care Act (ACA) includes provisions to help improve access to PSP treatments by requiring insurers to cover certain preventive services, including PSP screenings, without co-pays or deductibles o It also includes protections for people with pre-existing conditions, such as PSP
▪
Reimbursement for New Treatments:
o Reimbursement for new PSP treatments can be a complex and lengthy process, as insurers and government programs often require evidence of safety and effectiveness before providing coverage o This can create challenges for companies developing and marketing new treatments
▪
Value-Based Care:
o There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the value of treatments rather than simply the volume of treatments o Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 44
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population)
Source of Funding
Spend on Healthcare (%of Current Health Expenditure) 100%
100%
100%
100%
100%
0%
Government Expenditure
0%
xx
xx
xx
xx
xx
7%
Public Healthcare
44.
0%
8%
46.
47.
51.
51.
Private Health Insurance
Coverage
Out of Pocket
Private Coverage
9%
1%
6%
5%
5%
38.
37.
35.
32.
31.
Other
NA
NA
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Public healthcare coverage is provided by the government and includes programs like Public and Private
6.3%
4.08%
5.1%
3.8%
2.2%
2.4%
3.6%
GDP Growth (yoy)
Public is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities 14.7%
11.3%
15.5%
7.5%
4.2%
NA
NA
HC Spend Growth (yoy)
Private is a joint federal-state program that provides healthcare coverage to individuals with low income and limited resources
Reimbursement Market Trends
▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 45
5.2 Reimbursement Process for Diagnosis
The reimbursement process in the US healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪
Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪
Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided
▪
Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud
▪
Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule
▪
Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost of the service, such as deductibles, co-payments, or co-insurance In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 46
5.3 Reimbursement Process for Treatment
The reimbursement process in the US healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare FDA
provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪
Service or Treatment Provided: The healthcare provider performs a Market Authorization
service or treatment for the patient
▪
Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service Private Payers
Public Payers
provided
▪
Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment Health Technology Assessment
provided, and checking for any potential errors or fraud
▪
Payment: If the claim is approved, the insurance company or other 1
2
3
payer reimburses the healthcare provider for the service provided, Coding
Coverage
Payment
based on the negotiated payment rates or fee schedule Coding depends on availability code while coverage and payment process decisions are made through an HTA.
Illustrative
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential 47
Belgium Patient Support Programs (PSP) Market Analysis 6. Methodology & Scope
▪
Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions
▪
We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources
▪
For forecasting, the following parameters are considered:
❑
Market drivers and restraints along with their current and expected impacts
❑
Technological scenario and expected developments
❑
End use industry trends and dynamics
❑
Trends in the consumer behavior
❑
Regulatory scenario and expected developments
❑
Current capacity and expected capacity additions up to 2030
▪
We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate
▪
We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions
▪
All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪
Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)
Analysis Methodology
Our Analysis Methodology involves three critical stages: Data
Market Data Analysis
Interpretation &
Collection
& Statistical Model
Presentation
Secondary
Analysis &
Market Trends
Research
Interpretation
Primary
Market Sizing &
Insights
Research
Analysis
Proprietary
Data Triangulation &
Presentation &
Database
Validation
Reporting
Data Triangulation & Data Validation
Top Down Approach
Final
Final Market size break up to
Market
rest of segmentation
Size
Validation from
Arriving at market size
Primary Interview
of each segment
Summarization of revenue
generated from companies
Validation from
to arrive at total market size
Primary Interview
Revenue generated by products &
Final
services offered by companies
Summary
Bottom Up Approach
Key Benefits for Stakeholders from this Report Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors
Time Frame
Report Attribute
Details
Quantitative Units
Revenue in USD Million/Billion (Mn/Bn)
Base Year for
2022
Estimation
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Report Coverage
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
Customized Report
that is currently not a part of our scope as a
2023-
Forecast
part of customization
2030
Period
Pricing and purchase
Avail customized purchase options to meet
options
your exact research needs
A division of
Lifesciences Market
Research Reports you
can trust
Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get actionable insights to
take informed business
decisions
A large database of over 30,000 syndicated
market research reports in Healthcare Services and healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Elevate your business plans
with in-depth market analysis
and industry intelligence
Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Gain a competitive edge with
Insights10's customized
healthcare research solutions
Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Market Research Reports
across various categories
Healthcare Services
Digital
Medical
Healthcare
OTC &
Clinical
(Diseases & Drugs)
Health
Devices
Services
Nutraceuticals
Trials
FEATURED REPORTS
FREE SAMPLE REPORTS
TRENDING TOPICS
What makes us different?
30000+
22000+
2000+
1200+
Life science
Country
Rare & orphan
Reports
Market Research
Specific
Disease
Published
Reports
Reports
Reports
Annually
Table of Contents
Market Overview
Competitive Landscape
1
6
Growth Drivers &
Key Company Profiles
2
7
Growth Restraints
Epidemiology &
Policy & Regulatory
3
8
Disease type
Landscape
insights on
which our
reports are
Market Segmentation
based
4
9
Reimbursement Scenario
Market Share
5
10
Factors Driving Future Growth
Our Services
Market Research
Customized
Primary
Reports
Reports
Research
Database
Full-Time
Conference
Service
Engagement
Coverage
Competitive
Regulatory
Subscription
Intelligence
Compliance
Over the years, we have developed an in-depth experience of executing market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions
Research Projects Done
Our Research Process
01
02
03
04
05
Identification of
Market
Collection of
Collaboration
Verification &
Data
Dynamics
Data
of Data
Analysis
Statistical Databases
Company Websites/Annual Reports
Data
Sources
Trade Publications
We have access to multiple highly
Online Databases
reliable free and subscription data
sources. We have many years of
experience to understand which
Published Research Reports
sources are more dependable for what
and which to prefer for the reliable and
Whitepapers
latest information.
Press Releases of Key Market Players
What kind of data is presented
in our reports?
Our reports present data, which is:
Reliable
Expert-verified
Real
Comprehensive
Easy to read
The report is
The data is prepared
Allowing you to
Covers everything
You do not have to
prepared using a
by a team of highly
confidently make
you would need to
be a market expert
proven methodology
qualified &
smarter business
know about the
to understand what
and insightful
experienced research
and strategic
market including
really is happening
research
analysts & vetted by
decisions
market size,
on the market and
our local associates
competitive analysis
how it works
& much more
The team
“The business decision-making process is no longer as straightforward as it used to be. It requires insights generated at the right time, based on reliable data interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market research and are committed to providing our clients with the right intelligence and insights to make business decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep domain expertise, nuanced data at a country and
functional area level, and years of experience working with some of the best organizations in the world, generating insights that provides substantial competitive advantage.”
Dr. Purav Gandhi
Founder & CEO
Leadership Team
Dr. Purav Gandhi
Anish Swaminathan
Mukesh Nayak
Ritu Baliya
Founder & CEO
Director
Head – Marketing & Research
Engagement Manager
Purav is a physician and an entrepreneur
Anish has 15+ years of experience
Mukesh is an engineering graduate with
Ritu has over 6 years of experience in
with 12+ years of experience in Healthcare
in management consulting in the
an MBA in Marketing. He is a seasoned
strategy building, market assessments,
& Life Sciences industry spanning across
Life Sciences sector, and has
healthcare market research & marketing
market sizing, and RWE for global MNC
strategy, market access, health informatics
worked with diverse multinational
professional with a progressive
healthcare & biopharma clients across diff.
and RWE, digital health, analytics and data
firms in the US, India, Middle East
experience of over 20 years in Life
markets (America, Europe, Africa, APAC
science. Purav studied medicine from
and APAC regions. His primary
Sciences, Pharma and Medical Device
and Middle East). Her areas of expertise
Gujarat University and also completed his
area of interest is Customer and
sectors. With an in-depth understanding
include: Indentifying emerging trends in life
MBA from IIM-Kozhikode. Purav started
Market Strategy, Market Access,
of primary research, he has conducted
sciences industry, Competitor landscape
his career with Deloitte working on strategy
and Digital Health with special
hundreds of interviews of various
assessment, Disease opportunity
consulting engagements and also co-
focus on emerging markets like
stakeholders in pharma & healthcare &
assessments etc. She is a pro in secondary
founded ConvergeHealth by Deloitte.
Africa, Middle East and APAC.
completed several research projects
and primary research with a deep domain
across life sciences industry.
expertise in healthcare sector.
Our Team
Our Clients
Our Clients
… and many more
Do you have
any questions?
We would be happy to help.
Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
Thank you
We truly appreciate your business and
look forward to serving you.
www.insights10.com
